机制(生物学)
酪氨酸激酶
抗性(生态学)
医学
生物
内科学
生态学
哲学
受体
认识论
作者
Defa Wu,Qian Sun,Haolin Tang,Huan Xiao,Jiaxiang Luo,Liang Ouyang,Qiu Sun
标识
DOI:10.1016/j.drup.2024.101176
摘要
Over the past two decades, tyrosine kinase inhibitors (TKIs) have rapidly emerged as pivotal targeted agents, offering promising therapeutic prospects for patients. However, as the cornerstone of targeted therapies, an increasing number of TKIs have been found to develop acquired resistance during treatment, making the challenge of overcoming this resistance a primary focus of current research. This review comprehensively examines the evolution of TKIs from multiple perspectives, with particular emphasis on the mechanisms underlying acquired resistance, innovative drug design strategies, inherent challenges, and future directions.
科研通智能强力驱动
Strongly Powered by AbleSci AI